Compare AA & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AA | WST |
|---|---|---|
| Founded | 1888 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 17.9B |
| IPO Year | 2016 | 2004 |
| Metric | AA | WST |
|---|---|---|
| Price | $55.98 | $236.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $50.45 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 5.9M | 709.0K |
| Earning Date | 04-16-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.68% | 0.37% |
| EPS Growth | ★ 1580.77 | 1.49 |
| EPS | 4.37 | ★ 6.79 |
| Revenue | ★ $12,831,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $13.20 | $6.73 |
| Revenue Next Year | $0.14 | $6.07 |
| P/E Ratio | ★ $13.41 | $35.52 |
| Revenue Growth | ★ 7.87 | 1.95 |
| 52 Week Low | $21.53 | $187.43 |
| 52 Week High | $68.40 | $322.34 |
| Indicator | AA | WST |
|---|---|---|
| Relative Strength Index (RSI) | 39.59 | 44.07 |
| Support Level | $55.70 | $230.42 |
| Resistance Level | $66.71 | $251.73 |
| Average True Range (ATR) | 3.97 | 6.78 |
| MACD | -0.68 | -0.15 |
| Stochastic Oscillator | 3.54 | 27.48 |
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.